Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations

American Journal of Medicine

Volumn 120, Issue 11 SUPPL. 1, 2007, Pages

  Verbalis, Joseph G ^a   Goldsmith, Stephen R ^b   Greenberg, Arthur ^c   Schrier, Robert W ^d   Sterns, Richard H ^e  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antidiuretic hormone; Aquaretics; Hypo osmolality; Natriuresis; Syndrome of inappropriate antidiuretic hormone secretion; Vasopressin

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ARGIPRESSIN RECEPTOR; CONIVAPTAN; DIURETIC AGENT; GLUCOCORTICOID; HYDROCORTISONE; LIXIVAPTAN; MINERALOCORTICOID; N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; HEART FAILURE; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; MORBIDITY; MORTALITY; NATRIURESIS; OSMOLALITY; PATHOGENESIS; PATHOPHYSIOLOGY; POLYDIPSIA; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 35649016098     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.09.001     Document Type: Article

References (120)

1. Upadhyay A., Jaber B.L., and Madias N.E. Incidence and prevalence of hyponatremia. Am J Med 119 suppl 1 (2006) S30-S35
2. Verbalis J.G. The syndrome of inappropriate antidiuretic hormone secretion and other hypoosmolar disorders. In: Schrier R.W. (Ed). Diseases of the Kidney and Urinary Tract (2007), Lippincott Williams & Wilkins, Philadelphia, Pa 2214-2248
3. Sterns R.H., and Silver S.M. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med 119 suppl 1 (2006) S12-S16
4. Schrier R.W. Treatment of hyponatremia. [review]. N Engl J Med 312 (1985) 1121-1123
5. Robertson G.L. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 119 suppl 1 (2006) S36-S42
6. Schrier R.W. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119 suppl 1 (2006) S47-S53
7. Weisberg L.S. Pseudohyponatremia: a reappraisal. [review]. Am J Med 86 (1989) 315-318
8. Hillier T.A., Abbott R.D., and Barrett E.J. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 106 (1999) 399-403
9. Schrier R.W. Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17 (2006) 1820-1832
10. Beck L.H. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301 (1979) 528-530
11. Schrier R.W. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 113 (1990) 155-159
12. Almond C.S., Shin A.Y., Fortescue E.B., et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med 352 (2005) 1550-1556
13. Sonnenblick M., Friedlander Y., and Rosin A.J. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. [review]. Chest 103 (1993) 601-606
14. Sharabi Y., Illan R., Kamari Y., et al. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens 16 (2002) 631-635
15. Chow K.M., Szeto C.C., Wong T.Y., Leung C.B., and Li P.K. Risk factors for thiazide-induced hyponatraemia. QJM 96 (2003) 911-917
16. Friedman E., Shadel M., Halkin H., and Farfel Z. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 110 (1989) 24-30
17. Damaraju S.C., Rajshekhar V., and Chandy M.J. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery 40 (1997) 312-316 discussion: 316-317
18. Palmer B.F. Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 15 (2000) 262-268
19. Maesaka J.K., Gupta S., and Fishbane S. Cerebral salt-wasting syndrome: does it exist?. Nephron 82 (1999) 100-109
20. Bartter F.C., and Schwartz W.B. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42 (1967) 790-806
21. Michelis M.F., Fusco R.D., Bragdon R.W., and Davis B.B. Reset of osmoreceptors in association with normovolemic hyponatremia. Am J Med Sci 267 (1974) 267-273
22. Feldman B.J., Rosenthal S.M., Vargas G.A., et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352 (2005) 1884-1890
23. Decaux G., Vandergheynst F., Bouko Y., Parma J., Vassart G., and Vilain C. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 18 (2007) 606-612
24. Zerbe R., Stropes L., and Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 31 (1980) 315-327
25. Ikkos D., Luft R., and Olivecrona H. Hypophysectomy in man: effect on water excretion during the first two postoperative months. J Clin Endocrinol Metab 15 (1955) 553-567
26. Diederich S., Franzen N.F., Bahr V., and Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 148 (2003) 609-617
27. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321 (1989) 492-496
28. Ishikawa S., and Schrier R.W. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int 22 (1982) 587-593
29. Hanna F.W., and Scanlon M.F. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet 350 (1997) 755-756
30. Chinitz A., and Turner F.L. The association of primary hypothyroidism and inappropriate secretion of the antidiuretic hormone. Arch Intern Med 116 (1965) 871-874
31. Derubertis Jr. F.R., Michelis M.F., Bloom M.E., Mintz D.H., Field J.B., and Davis B.B. Impaired water excretion in myxedema. Am J Med 51 (1971) 41-53
32. Chen Y.-C., Cadnapaphornchai M.A., Yang J., et al. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am J Physiol Renal Physiol 289 (2005) F672-F678
33. Irving R.A., Noakes T.D., Buck R., et al. Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia. J Appl Physiol 70 (1991) 342-348
34. Speedy D.B., Noakes T.D., Rogers I.R., et al. Hyponatremia in ultradistance triathletes. Med Sci Sports Exerc 31 (1999) 809-815
35. Noakes T. Fluid replacement during marathon running. Clin J Sport Med 13 (2003) 309-318
36. Hew-Butler T., Almond C., Ayus J.C., et al. Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin J Sport Med 15 (2005) 208-213
37. Demanet J.C., Bonnyns M., Bleiberg H., and Stevens-Rocmans C. Coma due to water intoxication in beer drinkers. Lancet 2 (1971) 1115-1117
38. Thaler S.M., Teitelbaum I., and Berl T. "Beer potomania" in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis 31 (1998) 1028-1031
39. Barlow E.D., and DeWardener H.E. Compulsive water drinking. Q J Med 28 (1959) 235-258
40. Vieweg W.V., Robertson G.L., Godleski L.S., and Yank G.R. Diurnal variation in water homeostasis among schizophrenic patients subject to water intoxication. Schizophr Res 1 (1988) 351-357
41. de Leon J., Verghese C., Tracy J.I., Josiassen R.C., and Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 35 (1994) 408-419
42. Stuart C.A., Neelon F.A., and Lebovitz H.E. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Eng J Med 303 (1980) 1078-1082
43. Noakes T.D., Wilson G., Gray D.A., Lambert M.I., and Dennis S.L. Peak rates of diuresis in healthy humans during oral fluid overload. S Afr Med J 91 (2001) 852-857
44. Cheng J.C., Zikos D., Skopicki H.A., Peterson D.R., and Fisher K.A. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction. Am J Med 88 (1990) 561-566
45. Goldman M.B., Luchins D.J., and Robertson G.L. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 318 (1988) 397-403
46. Lee W.H., and Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 73 (1986) 257-267
47. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Haimark D., and Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
48. Zucker I.H., Share L., and Gilmore J.P. Renal effects of left atrial distension in dogs with chronic congestive heart failure. Am J Physiol 236 (1979) H554-H560
49. Zucker I.H., Gorman A.J., Cornish K.G., and Lang M. Impaired atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. Cardiovasc Res 19 (1985) 411-418
50. Abraham W.T., Lowes B.D., Ferguson D.A., et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4 (1998) 37-44
51. Schrier R.W., and Abraham W.T. Hormones and hemodynamics in heart failure. N Engl J Med 341 (1999) 577-585
52. Berl T., Henrich W.L., Erickson A.L., and Schrier R.W. Prostaglandins in the beta-adrenergic and baroreceptor-mediated secretion of renin. Am J Physiol 236 (1979) F472-F477
53. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). [review]. N Engl J Med 319 (1988) 1065-1072 [published correction appears in N Engl J Med. 1989;320:676]
54. Schrier R.W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). [review]. N Engl J Med 319 (1988) 1127-1134 [published correction appears in N Engl J Med. 1989;320:676]
55. Myers B.D., Deen W.M., and Brenner B.M. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37 (1975) 101-110
56. Ruf A.E., Kremers W.K., Chavez L.L., Descalzi V.I., Podesta L.G., and Villamil F.G. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11 (2005) 336-343
57. Porcel A., Diaz F., Rendon P., Macías M., Martín-Herrara L., and Girón-González J.A. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 162 (2002) 323-328
58. Schrier R.W., Niederberger M., Weigert A., and Gines P. Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis. [review]. Semin Liver Dis 14 (1994) 14-22
59. Martin P.Y., Gines P., and Schrier R.W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339 (1998) 533-541
60. Gerbes A.L., Gulberg V., Gines P., et al. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist. A randomized double-blind multicenter trial. Gastroenterology 124 (2003) 933-939
61. McManus M.L., Churchwell K.B., and Strange K. Regulation of cell volume in health and disease. N Engl J Med 333 (1995) 1260-1266
62. Pasantes-Morales H., Lezama R.A., Ramos-Mandujano G., and Tuz K.L. Mechanisms of cell volume regulation in hypo-osmolality. Am J Med 119 suppl 1 (2006) S4-S11
63. Sjoblom E., Hojer J., Ludwigs U., and Pirskanen R. Fatal hyponatraemic brain oedema due to common gastroenteritis with accidental water intoxication. Intensive Care Med 23 (1997) 348-350
64. Sterns R.H. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. Ann Intern Med 107 (1987) 656-664
65. Helwig F.C., Schutz C.B., and Kuhn H.P. Water intoxication: moribund patient cured by administration of hypertonic salt solution. JAMA 110 (1938) 644-645
66. Battison C., Andrews P.J., Graham C., and Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33 (2005) 196-202
67. Sterns R.H., Riggs J.E., and Schochet Jr. S.S. Osmotic demyelination syndrome following correction of hyponatremia. N Eng J Med 314 (1986) 1535-1542
68. Sterns R.H., Cappuccio J.D., Silver S.M., and Cohen E.P. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 4 (1994) 1522-1530
69. Brunner J.E., Redmond J.M., Haggar A.M., and Elias S.B. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 27 (1990) 61-66
70. Lien Y.H. Role of organic osmolytes in myelinolysis: a topographic study in rats after rapid correction of hyponatremia. J Clin Invest 95 (1995) 1579-1586
71. Soupart A., Silver S., Schrooeder B., Sterns R., and DeCaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 13 (2002) 1433-1441
72. Ellis S.J. Severe hyponatraemia: complications and treatment. QJM 88 (1995) 905-909
73. Tanneau R.S., Henry A., Rouhart F., et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. J Clin Psychiatry 55 (1994) 349-354
74. Cluitmans F.H., and Meinders A.E. Management of severe hyponatremia: rapid or slow correction [review]?. [See comments.]. Am J Med 88 (1990) 161-166
75. Karp B.I., and Laureno R. Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia. Medicine 72 (1993) 359-373
76. Ayus J.C., Krothapalli R.K., and Arieff A.I. Treatment of symptomatic hyponatremia and its relation to brain damage: a prospective study. N Engl J Med 317 (1987) 1190-1195
77. Nzerue C.M., Baffoe-Bonnie H., You W., Falana B., and Dai S. Predictors of outcome in hospitalized patients with severe hyponatremia. J Natl Med Assoc 95 (2003) 335-343
78. Ayus J.C., and Arieff A.I. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. [See comments.]. JAMA 281 (1999) 2299-2304
79. Verbalis J.G. Hyponatremia: endocrinologic causes and consequences of therapy. Trends Endocrinol Metab 3 (1992) 1-7
80. Lin S.H., Chau T., Wu C.C., and Yang S.S. Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline. Am J Med Sci 323 (2002) 259-262
81. Ashraf N., Locksley R., and Arieff A.I. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70 (1981) 1163-1168
82. Ayus J.C., Krothapalli R.K., and Arieff A.I. Changing concepts in treatment of severe symptomatic hyponatremia: rapid correction and possible relation to central pontine myelinolysis. Am J Med 78 (1985) 897-902
83. Robertson G.L. Posterior pituitary. In: Felig P., Baxter J., Broadus A., and Frohman L. (Eds). Endocrinology and Metabolism (1986), McGraw-Hill, New York, NY 338-385
84. List A.F., Hainsworth J.D., Davis B.W., Hande K.R., Greco F.A., and Johnson D.H. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 4 (1986) 1191-1198
85. Cherrill D.A., Stote R.M., Birge J.R., and Singer I. Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. Ann Intern Med 83 (1975) 654-656
86. Dousa T.P., and Wilson D.M. Effect of demethylchlorotetracycline on cellular action of antidiuretic hormone in vitro. Kidney Int 5 (1974) 279-284
87. Miller P.D., Linas S.L., and Schrier R.W. Plasma demeclocycline levels and nephrotoxicity: correlation in hyponatremic cirrhotic patients. JAMA 243 (1980) 2513-2515
88. Forrest Jr. J.N., Cox M., Hong C., Morrison G., Bia M., and Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 298 (1978) 173-177
89. Decaux G., Mols P., Cauchi P., and Delwiche F. Use of urea for treatment of water retention in hyponatraemic cirrhosis with ascites resistant to diuretics. BMJ 290 (1985) 1782-1783
90. Robertson G.L., Aycinena P., and Zerbe R.L. Neurogenic disorders of osmoregulation. Am J Med 72 (1982) 339-353
91. Bosch-Marce M., Poo J.L., Jimenez W., et al. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention. J Pharmacol Exp Ther 289 (1999) 194-201
92. Gadano A., Moreau R., Pessione F., et al. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis. J Hepatol 32 (2000) 38-42
93. Huang E.A., Feldman B.J., Schwartz I.D., Geller D.H., Rosenthal S.M., and Gitelman S.E. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 148 (2006) 128-131
94. Ayus J.C., Varon J., and Arieff A.I. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med 132 (2000) 711-714
95. Davis T.M., Singh B., and Sheridan G. Parasitic procrastination: late-presenting ovale malaria and schistosomiasis. Med J Aust 175 (2001) 146-148
96. Robertson G.L. Abnormalities of thirst regulation. Kidney Int 25 (1984) 460-469
97. Canuso C.M., and Goldman M.B. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. J Neuropsychiatry Clin Neurosci 11 (1999) 86-90
98. Kawai N., Baba A., and Suzuki T. Risperidone failed to improve polydipsia-hyponatremia of the schizophrenic patients. Psychiatry Clin Neurosci 56 (2002) 107-110
99. Decaux G. Is asymptomatic hyponatremia really asymptomatic?. Am J Med 119 suppl 1 (2006) S79-S82
100. Goldsmith S.R., and Gheorghiade M. Vasopressin antagonism in heart failure. J Am Coll Cardiol 46 (2005) 1785-1791
101. Licata G., Di Pasquale P., Parrinello G., et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Am Heart J 145 (2003) 459-466
102. Choudhury J., and Sanyal A.J. Treatment of ascites. Curr Treat Options Gastroenterol 6 (2003) 481-491
103. Thibonnier M., Conarty D.M., Preston J.A., Wilkins P.L., Berti-Mattera L.N., and Mattera R. Molecular pharmacology of human vasopressin receptors. Adv Exp Med Biol 449 (1998) 251-276
104. Knepper M.A. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol 272 pt 2 (1997) F3-F12
105. Kinter L.B., Ileson B.E., Caltabinol S., et al. Antidiuretic hormone antagonism in humans: are there predictors?. In: Jard S., and Jamison R. (Eds). Vasopressin (1991), John Libbey Eurotext, Paris 321-329
106. Ohnishi A., Orita Y., Okahara R., et al. Potent aquaretic agent: a novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. J Clin Invest 92 (1993) 2653-2659
107. 2-renal vasopressin receptor. J Pharmacol Exp Ther 316 (2006) 564-571
108. Lee C.R., Watkins M.L., Patterson J.H., et al. Vasopressin: a new target for the treatment of heart failure. Am Heart J 146 (2003) 9-18
109. 2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 91 (2006) 2145-2152
110. Greenberg A., and Verbalis J.G. Vasopressin receptor antagonists. Kidney Int 69 (2006) 2124-2130
111. Palm C., Pistrosch F., Herbrig K., and Gross P. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med 119 suppl 1 (2006) S87-S92
112. 2-receptor antagonist, for hyponatremia. N Engl J Med 355 (2006) 2099-2112
113. 2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 107 (2003) 2690-2696
114. Adrogue H.J., and Madias N.E. Hyponatremia. N Engl J Med 342 (2000) 1581-1589
115. Goldsmith S.R. Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure. Cleve Clin J Med 73 suppl 2 (2006) S20-S23
116. Gheorghiade M., Gattis W.A., O'Connor C.M., et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291 (2004) 1963-1971
117. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007) 1319-1331
118. Singh A., Blackwell J., and Neher J. Clinical inquiries: does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?. J Fam Pract 54 (2005) 370-372
119. 2 receptor antagonists?. Am J Med 119 suppl 1 (2006) S93-S96
120. Renneboog B., Musch W., Vandemergel X., Manto M.U., and DeCaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 119 (2006) 71 e1-e8